#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16780	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2438	828.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1680	1680	C	1066	C	1066	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27732	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4134	837.5	0	.	n	.	0	T695C	SNP	695	695	T	1354	1354	C	1049	C,T,G	1042,6,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27732	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4134	837.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1996	1996	A	1127	A,C	1124,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27732	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4134	837.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2630	2630	C	1002	C,T,A	999,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27732	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4134	837.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2704	2704	A	933	A	933	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27732	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4134	837.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3256	3256	C	914	C,A,G	910,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2330	folP	852	852	100.0	folP.l6.c4.ctg.1	2105	138.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1283	1285	AGC	220;221;223	A;G;C	220;221;223	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5432	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4012	169.1	1	SNP	p	S91F	0	.	.	271	273	TCC	887	889	TCC	205;207;206	T;C;C,T	205;207;205,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5432	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4012	169.1	1	SNP	p	D95N	0	.	.	283	285	GAC	899	901	GAC	214;215;214	G;A;C	214;215;214	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5432	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4012	169.1	1	SNP	p	D95G	0	.	.	283	285	GAC	899	901	GAC	214;215;214	G;A;C	214;215;214	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1532	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1757	108.7	0	.	p	.	0	D79N	NONSYN	235	237	GAT	819	821	AAT	191;189;187	A;A;T	191;189;187	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1532	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1757	108.7	0	.	p	.	0	A86T	NONSYN	256	258	GCG	840	842	ACG	205;206;208	A;C,T;G,A	205;205,1;207,1	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1532	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1757	108.7	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	897	899	CAC	242;244;245	C;A;C	242;244;245	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1532	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1757	108.7	0	.	p	.	0	S183N	NONSYN	547	549	AGT	1131	1133	AAT	146;145;143	A;A,T;T	146;144,1;143	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1532	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1757	108.7	0	.	p	.	0	M197I	NONSYN	589	591	ATG	1173	1175	ATA	136;136;136	A;T;A	136;136;136	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1532	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1757	108.7	1	SNP	p	G45D	0	.	.	133	135	GGC	717	719	GGC	178;175;175	G;G;C	178;175;175	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3549	186.0	1	SNP	p	D86N	0	.	.	256	258	GAC	889	891	GAC	237;243;243	G;A;C,A	237;243;242,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3549	186.0	1	SNP	p	S87R	0	.	.	259	261	AGT	892	894	AGT	242;244;246	A,C;G;T	241,1;244;246	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3549	186.0	1	SNP	p	S87W	0	.	.	259	261	AGT	892	894	AGT	242;244;246	A,C;G;T	241,1;244;246	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3549	186.0	1	SNP	p	S87I	0	.	.	259	261	AGT	892	894	AGT	242;244;246	A,C;G;T	241,1;244;246	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5288	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3549	186.0	1	SNP	p	S88P	0	.	.	262	264	TCC	895	897	TCC	246;247;248	T;C;C,T	246;247;247,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4448	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3332	166.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1888	1890	GGC	239;235;232	G;G,C;C	239;233,2;232	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1535	1537	GCA	246;248;249	G,C;C,G;A	245,1;247,1;249	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1538	1540	ATC	249;245;247	A,G;T;C	248,1;245;247	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1550	1552	GTG	261;267;265	G;T;G,A	261;267;264,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1550	1552	GTG	261;267;265	G;T;G,A	261;267;264,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2054	2056	ACC	234;240;242	A;C;C	234;240;242	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2108	2110	GCG	248;247;248	G;C;G	248;247;248	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2108	2110	GCG	248;247;248	G;C;G	248;247;248	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2231	2233	GGC	229;232;231	G;G;C,T	229;232;230,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2240	2242	GGC	233;234;233	G;G;C	233;234;233	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2961	185.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2258	2260	CCG	230;231;228	C;C;G	230;231;228	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5886	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3649	201.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1865	1867	CTG	216;216;212	C;T,C;G	216;215,1;212	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2662	porA	1146	1146	99.83	porA.l15.c17.ctg.1	2407	138.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	876	876	C	179	C	179	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	98.29	porB1b.l6.c4.ctg.1	2125	185.8	0	.	p	.	0	I45V	NONSYN	133	135	ATT	737	739	GTT	288;289;291	G;T;T	288;289;291	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	98.29	porB1b.l6.c4.ctg.1	2125	185.8	0	.	p	.	0	I75V	NONSYN	223	225	ATT	827	829	GTT	299;297;298	G,T;T,G;T	297,1;295,1;297	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	98.29	porB1b.l6.c4.ctg.1	2125	185.8	0	.	p	.	0	S89T	NONSYN	265	267	AGC	869	871	ACC	281;281;282	A,C;C;C	280,1;281;282	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	98.29	porB1b.l6.c4.ctg.1	2125	185.8	0	.	p	.	0	I98V	NONSYN	292	294	ATC	896	898	GTC	279;281;281	G;T;C,T	279;281;279,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	98.29	porB1b.l6.c4.ctg.1	2125	185.8	0	.	p	.	0	Y213_N214insRYAY	INS	637	637	T	1241	1241	T	293	T	293	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	98.29	porB1b.l6.c4.ctg.1	2125	185.8	0	.	p	.	0	R272H	NONSYN	814	816	CGT	1430	1432	CAT	243;245;244	C;A;T	243;245;244	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	98.29	porB1b.l6.c4.ctg.1	2125	185.8	1	SNP	p	G120K	1	.	.	358	360	AAG	962	964	AAG	254;255;257	A,G;A;G	252,2;255;257	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	98.29	porB1b.l6.c4.ctg.1	2125	185.8	1	SNP	p	N121D	0	.	.	361	363	AAC	965	967	AAC	258;256;258	A;A;C	258;256;258	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	98.29	porB1b.l6.c4.ctg.1	2125	185.8	1	SNP	p	A121N	1	.	.	361	363	AAC	965	967	AAC	258;256;258	A;A;C	258;256;258	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10986	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5327	257.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2205	2207	AAT	303;299;298	A;A;T	303;299;298	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1662	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1621	128.0	1	SNP	p	V57M	1	.	.	169	171	ATG	798	800	ATG	296;296;296	A;T,C;G	296;295,1;296	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
